Royal Bank of Canada
NBTX

Royal Bank of Canada’s Nanobiotix NBTX Stock Holding History

Royal Bank of Canada’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83K Buy
2,189
+364
+20% +$13.5K ﹤0.01% 5517
2026
Q1 		$56K Sell
1,825
-800
-30% -$21.1K ﹤0.01% 5441
2025
Q4 		$61K Buy
2,625
+2,500
+2,000% +$54.6K ﹤0.01% 5458
2025
Q3 		$2K Hold
125
– – ﹤0.01% 6892
2025
Q2 		$1K Sell
125
-11
-8% -$43 ﹤0.01% 6909
2025
Q1 		$0 Buy
136
+7
+5% +$24 ﹤0.01% 7092
2024
Q4 		$0 Buy
+129
New +$516 ﹤0.01% 7119
2024
Q3 		– Sell
-263
Closed -$1K – 7224
2024
Q2 		$1K Buy
263
+229
+674% +$1.38K ﹤0.01% 6861
2024
Q1 		$0 Sell
34
-271
-89% -$1.92K ﹤0.01% 7386
2023
Q4 		$2K Buy
+305
New +$1.93K ﹤0.01% 6822

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada's NBTX Position: Q2 2026 in Review

Royal Bank of Canada increased its Nanobiotix (NBTX) stake by 20% in Q2 2026, buying an estimated $13.5K and bringing the position to 2,189 shares worth $83K. The position accounts for ﹤0.01% of the portfolio, ranked #5517.

Royal Bank of Canada first reported a position in NBTX in Q4 2023 and has held it in 10 quarters since. 19 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • Royal Bank of Canada held 2,189 shares of Nanobiotix worth $83K as of Q2 2026.
  • Royal Bank of Canada bought 364 Nanobiotix shares in Q2 2026, an estimated $13.5K.
  • Nanobiotix made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5517 holding.
  • Royal Bank of Canada first reported a position in Nanobiotix in Q4 2023 and has held it in 10 quarters since.
  • 19 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.